CRISPR Based Technologies and Bio-products

Genome piece of writing and also the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will concentrate on the foremost recent developments among the employment of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

    Related Conference of CRISPR Based Technologies and Bio-products

    July 15-16, 2020

    12th World Congress and Expo on Stem Cell Research

    Prague, Czech Republic
    July 15-16, 2020

    25th World Biotechnology Congress

    London, UK
    September 21-22, 2020

    14th International Conference on Genomics & Pharmacogenomics

    Vancouver, Canada
    September 23-24, 2020

    24th European Biotechnology Congress

    Berlin, Germany
    October 19-20, 2020

    7th Asia Pacific Geriatrics and Gerontology Congress

    Tokyo, Japan
    October 23-24, 2020

    2nd International Conference on Biomarkers and Cancer Targets

    Cape Town, South Africa
    November 16-17, 2020

    International Conference on Genomics and Molecular Biology

    Lisbon, Portugal
    November 19-20, 2020

    24th European Biotechnology Congress (EBC_2020)

    London, UK
    November 23-24, 2020

    International Conference on Toxicogenomics

    Bali, Indonesia
    December 07-08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia

    CRISPR Based Technologies and Bio-products Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in